Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
BridgeBio Pharma (2CL.F) Q3 2024 Earnings
2CL.F
1
Aug
Confirmed
Q4 2023
Q2 2024
Q3 2024
-0.93
-0.68
-0.43
-0.19
Details
Expected EPS
-0.925011417
Actual EPS
-0.3614325
Surprise EPS
0.56
Surprise Percent
+60.93%
Description
BridgeBio Pharma (2CL.F) has reported earnings of -0.3614325 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login